First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

Title
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 371, Issue 23, Pages 2167-2177
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2014-12-04
DOI
10.1056/nejmoa1408440

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now